Open Access Journal

Publishing in all areas of basic, translational, and clinical endocrinology

J. Larry Jameson, MD, PhD
Executive Vice President, University of Pennsylvania for the Health System
Read full Bio

Article Types Accepted Include:

  • Research Articles
  • Mini-reviews
  • Perspectives
  • Case Reports
  • Methods and Tools
  • Databases
  • Images
  • Editorials
  • Endocrine Society Statements
Sign Up to Receive Alerts

Stay tuned to the launch of JES.

Email *

First Name *

Last Name *


From the Editor-in-Chief

“As the inaugural Editor-in-Chief of the Journal of the Endocrine Society, I am excited by the prospect that discoveries in endocrinology will be available as rapidly as possible following peer-review and editorial assessment. The Open Access format will provide ready access to high quality information for all physicians, scientists, students, and the public. We know that you will find its format and content interesting.”

J. Larry Jameson, MD, PhD, Executive Vice President, University of Pennsylvania for the Health System, Dean, Raymond and Ruth Perelman School of Medicine, Perelman Center for Advanced Medicine

Read an interview with Dr. Jameson in Endocrine News.

About the Journal

The Endocrine Society will expand its publication offerings to authors and readers with the Journal of the Endocrine Society (JES), an Open Access journal led by a distinguished international team of editors, publishing top-quality research in all areas of basic, translational, and clinical endocrinology. JES will provide rapid peer-review and continuous online publication of accepted, edited articles for citation, indexing, and discoverability. JES will publish a wide range of content relating to endocrinology, including basic, translational, and clinical research, clinical practice guidelines, mini-reviews, editorials, and perspectives. Images, case reports, articles about databases and methods, and innovative contributions such as interactive media will also be featured. Articles will be published shortly after acceptance and are provided with article-level metrics of usage and impact.

Subject Scope

Topic categories of articles that will be considered for JES are adrenal; diabetes, pancreatic and gastrointestinal hormones; growth, growth hormone, and growth factors; hormone action in cancer; lipids and cardiovascular; nuclear receptors and their ligands; obesity and adipocyte biology; parathyroid, bone, and mineral metabolism; pituitary and neuroendocrinology; reproductive biology and sex-based medicine; signaling pathways; and thyroid. The following cross-cutting terms will be used to further refine the topic categories: aging, autoimmunity and inflammation; bioinformatics; development; endocrine disruptors; genetics and genomics; health disparities; neoplasia; pediatrics; therapeutics; surgery; transcription and gene regulation; and protein regulation and proteomics.

Associate Editors

The following distinguished endocrinologists have agreed to serve JES as inaugural Associate Editors:

Andrew Arnold, MD, University of Connecticut, USA
Jim Fagin, MD, Memorial Sloan-Kettering Cancer Center, USA
Ken Ho, MD, Princess Alexandra Hospital, Brisbane, Australia
Takashi Kadowaki, MD, PhD University of Tokyo, Japan
Marta Korbonits, MD, PhD Queen Mary University, London, UK
Carol Lange, PhD, University of Minnesota, USA
John Leahy, MD, University of Vermont, USA
Ana Claudia Latronico, MD, Sao Paulo University, Brazil
Eun-Jig Lee, MD, Yonsei University, S. Korea
Luca Persani, MD, PhD University of Milan, Italy
Margaret Shupnik, PhD, University of Virginia, USA
Paul Stewart, MD, University of Leeds, UK
Nancy Weigel, PhD, Baylor College of Medicine, USA
Bulent Yildiz, MD, Hacettepe University, Turkey

Want to be considered as a Reviewer for the JES?

Write to us

Download Open Access Journal FAQ

What people are saying about the Journal of the Endocrine Society

Never has there been so much excitement as we preside over the birth of not just a new journal but of a new era in endocrine publishing. Reflecting the Endocrine Society’s commitment to remain at the forefront of endocrine publishing, to maintain its global reach and to continue a strong tradition of innovation, the new open-access, global, on-line journal will provide ready access to the best endocrinology research, bench to bedside to community across the full spectrum of endocrinology and metabolism.

Professor Peter Fuller AM, PhD, FRACP, Associate Director, Hudson Institute, Head, Endocrinology Unit, Monash Health, Australia

The newest Endocrine Society journal is also its most novel: global in its reach, all-encompassing in its subject matter, and inviting with an open access format.This new on-line journal with unprecedented flexibility in format (because it is paper-free) should be an exciting adventure to be part of. And a strong editorial board guarantees its quality, influence, and success.

Henry (Hank) Morris Kronenberg, MD, Chief, Endocrine Unit, Physician, Department of Medicine, Massachusetts General Hospital